MBR Technology
HAR has completed a 8 months pilot test on pharmaceutical effluent in China.
The goal of the project was to demonstrate the efficiency of our membrane bioreactor technology, bioHARŪ, on different streams that are not suitable for a treatment with traditional technology.
COD inlet values have been fluctuating between 7.000 mg/l and 98.000 mg/l and the COD removal has been averaging between 87% and 96%, reaching a final value between 400 mg/l and 4.000 mg/l, depending on the type of stream that was treated.
A post-treatment by membranes easily allowed to reach a final COD value of the treated water lower than 100 ppm, a water quality suitable for reuse inside the factory. |
